210 related articles for article (PubMed ID: 30155576)
1. TCR repertoire profiling of tumors, adjacent normal tissues, and peripheral blood predicts survival in nasopharyngeal carcinoma.
Jin YB; Luo W; Zhang GY; Lin KR; Cui JH; Chen XP; Pan YM; Mao XF; Tang J; Wang YJ
Cancer Immunol Immunother; 2018 Nov; 67(11):1719-1730. PubMed ID: 30155576
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive model based on temporal dynamics of peripheral T cell repertoire for predicting post-treatment distant metastasis of nasopharyngeal carcinoma.
Zhang Y; Zhu Y; Wang J; Xu Y; Wang Z; Liu Y; Di X; Feng L; Zhang Y
Cancer Immunol Immunother; 2022 Mar; 71(3):675-688. PubMed ID: 34342668
[TBL] [Abstract][Full Text] [Related]
3. Joint quantitative measurement of hTERT mRNA in both peripheral blood and circulating tumor cells of patients with nasopharyngeal carcinoma and its clinical significance.
Fu X; Shen C; Wang H; Chen F; Li G; Wen Z
BMC Cancer; 2017 Jul; 17(1):479. PubMed ID: 28693532
[TBL] [Abstract][Full Text] [Related]
4. Higher IGFBP-1 to IGF-1 serum ratio predicts unfavourable survival in patients with nasopharyngeal carcinoma.
Feng X; Lin J; Xing S; Liu W; Zhang G
BMC Cancer; 2017 Jan; 17(1):90. PubMed ID: 28143425
[TBL] [Abstract][Full Text] [Related]
5. TCR repertoire characteristics predict clinical response to adoptive CTL therapy against nasopharyngeal carcinoma.
Wang G; Mudgal P; Wang L; Shuen TWH; Wu H; Alexander PB; Wang WW; Wan Y; Toh HC; Wang XF; Li QJ
Oncoimmunology; 2021; 10(1):1955545. PubMed ID: 34377592
[TBL] [Abstract][Full Text] [Related]
6. Immunophenotyping at the time of diagnosis distinguishes two groups of nasopharyngeal carcinoma patients: implications for adoptive immunotherapy.
Li J; Chen QY; Mo H; Zhang YL; Huang ZF; Zeng YX
Int J Biol Sci; 2011; 7(5):607-17. PubMed ID: 21614153
[TBL] [Abstract][Full Text] [Related]
7. T cell receptor repertoire profiling predicts the prognosis of HBV-associated hepatocellular carcinoma.
Lin KR; Deng FW; Jin YB; Chen XP; Pan YM; Cui JH; You ZX; Chen HW; Luo W
Cancer Med; 2018 Aug; 7(8):3755-3762. PubMed ID: 29947152
[TBL] [Abstract][Full Text] [Related]
8. High expression of Zinc-finger protein X-linked is associated with reduced E-cadherin expression and unfavorable prognosis in nasopharyngeal carcinoma.
Li Y; Yan X; Yan L; Shan Z; Liu S; Chen X; Zou J; Zhang W; Jin Z
Int J Clin Exp Pathol; 2015; 8(4):3919-27. PubMed ID: 26097576
[TBL] [Abstract][Full Text] [Related]
9. Correlations of the expressions of c-Jun and Egr-1 proteins with clinicopathological features and prognosis of patients with nasopharyngeal carcinoma.
Zhong JT; Wang HJ; Yu J; Zhang JH; Wang SF; Yang X; Su W
Cancer Biomark; 2017; 19(2):213-220. PubMed ID: 28269757
[TBL] [Abstract][Full Text] [Related]
10. Use of immunological studies in evaluating the clinical course of nasopharyngeal carcinoma.
Sawaki S; Kawamura A; Tachibana T
IARC Sci Publ (1971); 1978; (20):575-85. PubMed ID: 215534
[TBL] [Abstract][Full Text] [Related]
11. The Infiltration of ICOS
Zhang G; Xu Y; Zhou H
Pathol Oncol Res; 2020 Jan; 26(1):365-370. PubMed ID: 30361907
[TBL] [Abstract][Full Text] [Related]
12. Fatty acid synthase-associated protein with death domain: a prognostic factor for survival in patients with nasopharyngeal carcinoma.
Li J; Wen Q; Xu L; Wang W; Luo J; Chu S; Xie G; Shi L; Huang D; Li J; Fan S
Hum Pathol; 2014 Dec; 45(12):2447-52. PubMed ID: 25305096
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of IGF-1 serum levels as diagnostic marker of nasopharyngeal carcinoma.
M'hamdi H; Baizig NM; ELHadj OE; M'hamdi N; Attia Z; Gritli S; Gamoudi A; El May MV; A El May
Immunobiology; 2016 Nov; 221(11):1304-8. PubMed ID: 27312888
[TBL] [Abstract][Full Text] [Related]
14. Aberrant SATB1 expression is associated with Epstein-Barr virus infection, metastasis and survival in human nasopharyngeal cells and endemic nasopharyngeal carcinoma.
Deng YF; Zhou DN; Pan ZY; Yin P
Int J Clin Exp Pathol; 2014; 7(5):2454-61. PubMed ID: 24966956
[TBL] [Abstract][Full Text] [Related]
15. Human Leukocyte Antigen-A Allele Distribution in Nasopharyngeal Carcinoma Patients Showing Anti-Melanoma-Associated Antigen A or Synovial Sarcoma X-2 T Cell Response in Blood.
Fan PW; Huang L; Chang XM; Feng YN; Yao X; Peng YC; Dong T; Wang RZ
Chin Med J (Engl); 2018 Jun; 131(11):1289-1295. PubMed ID: 29786040
[TBL] [Abstract][Full Text] [Related]
16. Co-expression of AFAP1-AS1 and PD-1 predicts poor prognosis in nasopharyngeal carcinoma.
Tang Y; He Y; Shi L; Yang L; Wang J; Lian Y; Fan C; Zhang P; Guo C; Zhang S; Gong Z; Li X; Xiong F; Li X; Li Y; Li G; Xiong W; Zeng Z
Oncotarget; 2017 Jun; 8(24):39001-39011. PubMed ID: 28380458
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of the NKG2D ligand ULBP4 may be an indicator of poor prognosis in patients with nasopharyngeal carcinoma.
Xu Y; Zhou L; Zong J; Ye Y; Chen G; Chen Y; Liao X; Guo Q; Qiu S; Lin S; Chen H; Pan J
Oncotarget; 2017 Jun; 8(26):42007-42019. PubMed ID: 28159927
[TBL] [Abstract][Full Text] [Related]
18. CD3+T-lymphocyte infiltration is an independent prognostic factor for advanced nasopharyngeal carcinoma.
Al-Rajhi N; Soudy H; Ahmed SA; Elhassan T; Mohammed SF; Khoja HA; Ghebeh H
BMC Cancer; 2020 Mar; 20(1):240. PubMed ID: 32199452
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of MMP9 is correlated with poor prognosis of nasopharyngeal carcinoma.
Liu Z; Li L; Yang Z; Luo W; Li X; Yang H; Yao K; Wu B; Fang W
BMC Cancer; 2010 Jun; 10():270. PubMed ID: 20534121
[TBL] [Abstract][Full Text] [Related]
20. The detection and significance of T cells in nasopharyngeal carcinoma patients.
Chen M; Jin F; Ma L
J Cancer Res Ther; 2018 Jun; 14(Supplement):S331-S335. PubMed ID: 29970685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]